Hormesis, an update of the present position

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 6, 2003, Pages 921-933

  Johansson, Lennart ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hormesis; LNT model; Low dose radiation

Indexed keywords

CARCINOGEN;

ANIMAL EXPERIMENT; CANCER RISK; CARCINOGENESIS; CELL; DOSE RESPONSE; ENVIRONMENT; EPIDEMIOLOGICAL DATA; HORMESIS; IN VITRO STUDY; IONIZING RADIATION; LOW ENERGY RADIATION; NONHUMAN; POPULATION; RADIOBIOLOGY; REVIEW;

EID: 0038037855     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1185-2     Document Type: Review

References (157)

1. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. ICRP Publication 80. Oxford: Pergamon Press, 1998.
2. Overbeek F, Pauwels EKJ, Broerse JJ. Carcinogenic risks in diagnostic nuclear medicine: biological and epidemiological considerations. Eur J Nucl Med 1994; 21:997-1012.
3. International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Oxford: Pergamon Press, 1991,
4. National Council on Radiation Protection and Measurements. Evaluation of the linear-nonthreshold dose-response model for ionizing radiation. NCRP Report No. 136. Bethesda, Maryland: NCRP, 2001.
5. Kathren RL. Pathway to a paradigm: The linear nonthreshold dose-response model in historical context: the American Academy of Health Physics 1995 Radiology Ccentennial Hartman Oration. Health Phys 1996; 70:621-635.
6. Trott KR, Rosemann M. Molecular mechanisms of radiation carcinogenesis and the linear, non-threshold dose response model of radiation risk. Radiat Environ Biophys 2000; 39:79-87.
7. Becker K. Threshold or no threshold, that is the question. Radiat Prot Dosim 1997; 71:3-5.
8. Heidenreich WF, Paretzke HG, Jacob P. No evidence for increased tumor rates below 200 mSv in the atomic bomb survivor data. Radiat Environ Biophys 1997; 36:205-207.
9. Hoel DG, Li P. Threshold models in radiation carcinogenesis. Health Phys 1998; 75:241-250.
10. Calabrese EJ. Hormesis: changing view of the dose-response, a personal account of the history and current status. Mutat Res 2002; 511:181-189.
11. Upton AC. Radiation hormesis: data and interpretations. Crit Rev Toxicol 2001; 31:681-695.
12. Cameron J. Is radiation an essential trace energy? Physics and Society 2001; 30:14-16.
13. United Nations. Sources and effects of ionizing radiation. UNSCEAR 1994 Report to the General Assembly with scientific annexes. Annex B, Adaptive responses to radiation in cells and organisms. New York: United Nations, 1994.
14. Skov KA. Radioresponsiveness at low doses: hyper radiosensitivity and increased radioresistance in mammalian cells. Mutat Res 1999; 430:639-650.
15. Caney C, Bulmer JT, Sing G, Lukka H, Rainbow AJ. Pre-exposure of human squamous carcinoma cells to low-doses of γ-rays leads to an increased resistance to subsequent low-dose cisplatin treatment. Int J Radiat Biol 1999; 75:963-972.
16. Azzam EI, de Toledo SM, Raaphorst GP, Mitchel REJ. Low-dose ionizing radiation decreases the frequency of neoplastic transformation to a level below the spontaneous rate in C3H 10T1/2 Cells. Radiat Res 1996; 146:369-373.
17. Redpath JL, Liang D, Taylor TH, Christie C, Elmore E. The shape of the dose-response curve for radiation-induced neoplastic transformation in vitro: evidence for an adaptive response against neoplastic transformation at low doses of low-LET radiation. Radiat Res 2001; 156:700-707.
18. Pollycove M. The issue of the decade: hormesis. Eur J Nucl Med 1995; 22:399-401.
19. Mossman K. Deconstructing radiation hormesis. Health Phys 2001; 80:263-269.
20. Ron E. Ionizing radiation and cancer risk evidence from epidemiology. Radiat Res 1998: 150:S30-S41.
21. Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part 1. Cancer: 1950-1990. Radiat Res 1996; 146:1-27.
22. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part 11: solid tumors, 1958-1987. Radiar Res 1994; 137:S17-S67.
23. Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 1994; 137:S68-S97.
24. Pierce DA, Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res 2000; 154:178-186.
25. Schull WJ. Radioepidemiology of the A-bomb survivors. Health Phys 1996; 70:798-803.
26. Chomentowski M, Kellerer AM, Pierce DA. Radiation dose dependencies in the atomic bomb survivor cancer mortality data: a model-free visualization. Radiat Res 2000; 153:289-294.
27. United Nations. Sources and effects of ionizing radiation. UNSCEAR 2000 report to the general assembly with scientific annexes. Volume II: Effects. Annex 1, Epidemiological evaluation of radiation induced cancer. New York: United Nations, 2000.
28. Little MP, Weiss HA, Boice JD Jr, Darby SC, Day NE, Muirhead CR. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer and in patients treated for ankylosing spondylitis. Radiat Res 1999; 152:280-292.
29. Darby SC, Doll R, Gill SK, Smith PG. Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 1987; 55:179-190.
30. Inskip PD, Kleinerman RA, Stovall M, et al. Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign desease. Radiat Res 1993; 135:108-124.
31. Damber L, Larsson LG, Johansson L, Norin T. A cohort study with regard to the risk of haematological malignancies in patients treated with X-rays for benign lesions in the locomotor system. I. Epidemiological analysis. Acta Oncol 1995; 34:713-719.
32. Davis FG, Boice JD Jr, Hrubec Z, Monson RR. Cancer mortality in a radiation-exposed cohort of Massachussets tuberculosis patients. Cancer Res 1989; 49:6130-6136.
33. Mattsson A, Rudén BI, Palmgren J, Rutqvist LE. Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease. Br J Cancer 1995; 72:1054-1061.
34. Boice JD Jr, Engholm G, Kleinerman RA, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 1988; 116:3-55.
35. Kellerer M. The Southern Urals radiation studies. A reappraisal of the current status. Radiat Environ Biophys 2002; 41:307-316.
36. Little MP, Muirhead CR. Curvature in the cancer mortality dose response in Japanese atomic bomb survivors: absence of evidence of threshold. Int J Radiat Biol 1998; 74:471-480.
37. Little MP, Muirhead CR. Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors. Int J Radiat Biol 2000; 76:939-953.
38. Di Majo V. Carcinogenesis in laboratory mice after low doses of ionizing radiation. Radial Res 2003; 159:102-108.
39. Clarke RH. Control of low level radiation exposure: what is the problem and how can in be solved? Health Phys 2001; 80:391-396.
40. Clarke RH. Control of low-level radiation exposure: time for a change? J Radiol Prot 1999; 19:107-115.
41. International Commission on Radiological Protection. A report on progress towards the new recommendations: a communication from the International Commission on Radiological Protection. J Radiol Prot 2001; 21:113-123.
42. Trosko JE. Role of low-level ionizing radiation in multi-step carcinogenic process. Health Phys 1996; 70:812-822.
43. Little JB. Radiation carcinogenesis. Carcinogenesis 2000; 2:397-404.
44. United Nations. Sources and effects of ionizing radiation. UNSCEAR 2000 Report to the General Assembly with scientific annexes. Volume 11: effects. Annex G, Biological effects at low radiation doses. New York: United Nations, 2000.
45. Cunniffe S, O'Neill P. The complexity of radiation-induced DNA damage as revealed by exposure to cell extracts. Radiat Res 1999; 152:421-427.
46. Cohen BL. Cancer risk from low-level radiation. Am J Roentgenol 2002; 179:1137-1143.
47. Pollycove M, Feinendegen LE. Biologic response to low doses of ionizing radiation: detriment versus hormesis. Part 2. Dose responses of organisms. J Nucl Med 2001; 42:26N-37N.
48. Tubiana M. Radiation risks in perspective: radiation-induced cancer among cancer risks. Radiat Environ Biophys 2000; 39:3-16.
49. Goldman M. Cancer risk of low-level exposure. Science 1996; 271:1821-1822.
50. Feinendegen LE, Pollycove M. Biologic response to low doses of ionizing radiation: detriment versus hormesis. J Nucl Med 2001; 42:17N-27N.
51. Walinder G. Has radiation protection become a health hazard? Madison, Wis.: Medical Physics Publishing, 2000.
52. Sax K. The stimulation of plant growth by ionizing radiation. Radiat Botany 1963; 3:179-186.
53. Calabrese EJ, Baldwin LA. Radiation hormesis: its historical foundations as a biological hypothesis. Hum Exper Toxicol 2000; 19:41-75.
54. Calabrese EJ, Baldwin LA. Defining hormesis. Hum Exp Toxicol 2002; 21:91-97.
55. Parsons PA. Radiation hormesis: challenging LNT theory via ecological and evolutionary considerations. Health Phys 2002; 82:513-516.
56. Beckman KB, Ames BN. The free radical theory of aging matutes. Physiol Rev 1998; 78:547-581.
57. Wei Y-H, Lee H-C. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med 2002; 227:671-682.
58. Parsons PA. Hormesis: an adaptive expectation with emphasis on ionizing radiation. J Appl Toxicol 2000; 20:103-112.
59. Calabrese EJ, Baldwin LA, Holland CD. Hormesis: a highly generalizable and reproducible phenomenon with important implications for risk assessment. Risk Analysis 1999; 19:261-281.
60. Müller WA. Low radiation doses from internal alpha-particle emitters induce late bone tumors but may also prolong lifetime. Radiat Res 1999; 152:S163.
61. van Wyngaarden K, Pauwels E. Hormesis: are low doses of ionizing radiation harmful or beneficial? Eur J Nucl Med 1995; 22:481-486.
62. Luckey TD. Nurture with ionizing radiation: a provocative hypothesis. Nutr Cancer 1999; 34:1-11.
63. Mine M, Okumura Y, Ichimaru M, Nakamura T, Kondo S. Apparently beneficial effect of low to intermediate doses of A-bomb radiation on human lifespan. Int J Radiat Biol 1990; 58:1035-1043.
64. Zaider M. The risk of leukemia from low doses of low-LET radiation. Mathematical and Computer Modelling 2001; 33:1307-1313.
65. Cologne JB, Preston DL. Longevity of atomic-bomb survivors. Lancet 2000; 356:302-307.
66. Cardis E, Richardson D, Kesminiene A. Radiation risk estimates in the beginning of the 21st century. Health Phys 2001; 80:349-361.
67. Baillargeon J. Characterstics of the healthy worker effect. Occup Med 2001; 16:359-366.
68. Matanoski GM. Health effects of low-level radiation in shipyard workers, final report. Baltimore, Md.: DOE. DE-AC02-79, EVI0095. 1991
69. Rinsky RA, Zumwalde RD, Waxweiler RJ, et al. Cancer mortalily at a naval nuclear shipyard. Lancet 1981; 8214:231-235.
70. Stern FB, Waxweiler RA, Beaumont JJ, et al. A case-control study of leukemia at a naval nuclear shipyard. Am J Epidemiol 1986; 123:980-992.
71. Cardis E, Gilbert ES, Carpenter L, et al. Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res 1995; 142:117-132.
72. Smith PG, Doll R. Mortality from cancer and all causes among British radiologists. Br J Radiol 1981; 54:187-194.
73. Berrington A, Darby SC, Weiss HA, Doll R. 100 years of observation on British radiologists: mortality from cancer and other causes 1897-1997. Br J Radiol 2001; 74:507-519.
74. Mohan AK, Hauptmann M, Linet MS, et al. Breast cancer mortality among female radiologic technologists in the United States. J Natl Cancer Inst 2002; 94:943-948.
75. Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JD Jr. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 2002; 158:220-235.
76. Rossi HH, Zaider M. Radiogenic lung cancer: the effects of low doses of low linear energy transfer (LET) radiation. Radiat Environ Biophys 1997; 36:85-88.
77. Miller AB, Howe GR, Sherman GJ, Lindsay JP, Yaffe MJ, Dinner PJ, Risch HA, Preston DL. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 1989; 321:1285-1289.
78. Howe GR. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the Atomic Bomb survivors study. Radiat Res 1995; 142:295-304.
79. Nair MK, Nambi KSV, Sreedvi Amma N, Gangadharan P, Jayalekshmi P, Jayadevan S, Cherian V, Reghuram KN. Population study in the high natural background radiation area in Kerala, India. Radiat Res 1999; 162:S145-S148.
80. Jaikrishnan G, Andrews VJ, Thampi MV, Koya PKM, Rajan VK, Chaunan PS. Genetic monitoring of the human population from high-level natural radiation areas of Kerala on the southwest cost of India. I. Prevalence of congenital malformations in newborns. Radiat Res 1999; 152:S149-S152.
81. Cheriyan VD, Kurien CJ, Das B, Ramachandran EN, Karuppasamy CV, Thampi MV, George KP, Kesavan PC, Koya PKM, Chauhan PS. Genetic monitoring of the human population from high-level natural radiation areas of Kerala on the southwest cost of India. II. Incidence of numerical and structural chromosomal aberrations in the lymphocytes of newborns. Radiat Res 1999; 152:S154-S158.
82. Ghiassi-nejad M. Mortazavi SMJ, Cameron JR, Niroomand-Rad A, Karam PA. Very high background radiation areas of Ramsar, Iran: preliminary biological studies. Health Phys 2002; 82:87-93.
83. Wei L-X, Sugahara T. Risk assessment based on an epidemiological study in a high background radiation area. A China-Japan cooperative research. International Congress Series 2002; 1225:267-275.
84. Jagger J. Natural background radiation and cancer death in Rocky Mountains states and Gulf Coast states. Health Phys 1998; 75:428-430.
85. Cohen BL. Lung cancer rates vs. mean radon level in U.S. counties of various characteristics. Health Phys 1997; 72:114-119.
86. Committee on Health Risks of Exposure to Radon (BEIR VI) National Research Council. Health effects of exposure to radon. Washington D.C.: National Academy Press, 1999.
87. Lubin JH, Boice JJD, Edling C, et al. Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J Natl Cancer Inst 1995; 87:817-827.
88. Luebeck EG, Heidenreich WF, Hazelton WD, Paretzke HG, MooIgavkar SH. Biological based analysis of the data for the Colorado uranium miners cohort: age, dose and dose-rate effects. Radiat Res 1999; 152:339-351.
89. Field RW, Becker K. Does exposure to residential radon increase the risk of lung cancer? Radiat Prot Dosim 2001; 94:75-81.
90. Lubin JH, Boice JD Jr. Lung cancer risk from residential radon: meta-analysis of eight epidemiological studies. J Natl Cancer Inst 1997; 89:49-57.
91. Laurier D, Valenty M, Tirmarche M. Radon exposure and the risk of leukaemia: a review of epidemiological data. Health Phys 2001; 81:272-288.
92. Pershagen G, Åkerblom G, Axelson O, Clavensjö B, Damber L, Desai G, Enflo A, Lagarde F, Mellander H, Svartengren M, Swedjemark GA. Residential radon exposure and lung cancer in Sweden. N Engl J Med 1994; 330:159-164.
93. Becker K. Residential radon and the LNT hypothesis. International Congress Series 2002; 1225:259-266.
94. Lagarde F, Pershagen G. Parallel analyses of individual and ecological data on residential radon, cofactors and lung cancer in Sweden. Am J Epidemiol 1999; 149:268-274.
95. Leenhouts HP. Radon-induced lung cancer in smokers and non-smokers: risk implications using a two-mutation carcinogenisis model. Radiat Environ Biophys 1999; 38:57-71
96. Stidley CA, Samet JM. A review of ecological sudies of lung cancer and indoor radon. Health Phys 1993; 65:234-251.
97. Lagarde F, Axelsson G, Damber L, Mellander H, Nyberg F, Pershagen G. Residential radon and lung cancer among never-smokers in Sweden. Epidemiology 2001; 12:396-404.
98. Neuberger JS, Gesell TF. Residential radon exposure and lung cancer: risk in nonsmokers. Health Phys 2002; 83:1-18.
99. Cohen BL. A test of the linear no-threshold theory of radiation carcinogenesis. Environ Res 1990; 53:193-220.
100. Cohen BL. Test of the linear no-threshold theory of radiation carcinogenesis for inhaled radon decay products. Health Phys 1995; 68:157-174.
101. Lubin JH. On the discrepancy between epidemiologic studies in individuals of lung cancer and residential radon and Cohen's ecologic regression. Health Phys 1998; 75:4-10.
102. Field RW, Smith BJ, Lynch CF. Cohen's paradox. Health Phys 1999; 77:328-329.
103. Goldsmith JR. The residential radon-lung cancer association in U.S. counties: a commentary. Health Phys 1999; 76:553-557.
104. 222Rn exposure and lung cancer: testing the linear no-threshold theory with ecological data. Health Phys 1998; 75:31-33.
105. Wolff S, Afzal V, Wienke JJ, Olivieri G, Michaeli A. Human lymphocytes exposed to low doses of ionizing radiations become refractory to high doses of radiations as well as to chemical mutagens that induce double strand breaks in DNA. Int J Radiat Biol 1988; 53:39-49.
106. Shadley JD, Afzal V, Wolff S. Characterization of the adaptive response to ionizing radiationinduced by low doses of x-rays to human lymphocytes. Radiat Res 1987; 111:511-517.
107. Wojcik A, Tuschl H. Indications of an adaptive response in C57BL mice pre-exposed in vivo to low doses of ionizing radiation. Mutat Res 1990; 243:67-73.
108. Cai L, Liu SZ. Induction of cytogenetic adaptive response of somatic and germ cells in vivo and in vitro by low-dose X-irradiation. Int J Radiat Biol 1990; 58:187-194.
109. Wolff S. Is radiation all bad? The research for adaption. Radiat Res 1992; 131:117-123.
110. Shadley JD. Chromosomal adaptive response in human lymphocytes. Radiat Res 1994; 138:S9-S12.
111. Seoung J, Suh CO, Kim GE. Adaptive response to ionizing radiation induced by low doses of gamma rays in human cell lines. Int J Radiat Oncol Biol Phys 1995; 33:869-874.
112. Raaphorst GP, Boyden S. Adaptive response and its variation in human normal and tumour cells. Int J Radiat Biol 1999; 73:865-873.
113. 3H beta particles in normal human fibroblasts. Radiat Res 2002; 158:181-186.
114. Pereira Luís JH, Póvoa VL. Individual variability of adaptive respons of human lymphocyte primed with low dose gamma rays. In: Sugahara T, Sagan LA, Aoyama T, eds. Low dose irradiation and biological defence mechanisms. Amsterdam: Elsevier Science; 1992:315-317.
115. Sorensen K, Attix CM, Christian AT, Wyrobek AJ, Tucker JD. Adaptive response induction and variation in human lymphoblastoid cell lines. Mutat Res 2002; 519:15-24.
116. Vijayalaxmi, Leal BZ, Deahl TS, Meltz ML. Variability in adaptive response to low dose radiation in human blood lymphocytes: consistent results from chromosome aberrations and micronuclei. Mutat Res 1995; 348:45-50.
117. Cregan SP, Brown DL, Mitchel REJ. Apoptosis and the adaptive response in human lymphocytes. Int J Radiat Biol 1999; 75:1087-1094.
118. Robson T, Joiner MC, Wilson GD, et al. A novel human stress response-related gene with a potential role in induced radioresistance. Radiat Res 1999; 152:451-461.
119. Sasaki MS, Ejima Y, Tachibana A, Yamada T, Ishizaki K, Shimizu T, Nomura T. DNA damage response pathway in radioadaptive response. Mutat Res 2002; 504:101-118.
120. Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys 2001; 49:379-389.
121. Joiner MC, Lambin P, Malaise EP, Robson T, Arrand JE, Skov KA, Marples B. Hypersensitivity to very single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutat Res 1996; 358:171-183.
122. Suzuki K, Kodama S, Watanabe M. Extremely low-dose ionizing radiation causes activation of mitogen-activated protein kinase pathways and enhances proliferation of normal human diploid cells. Cancer Res 2001; 61:5396-5401.
123. Wang GJ, Cai L. Induction of cell-proliferation hormesis and cell-survival adaptive response in mouse hematopoietic cells by whole-body low-dose radiation. Toxicol Sci 2000; 53:369-376.
124. Planel H, Soleilhavoup JP, Tixador R, et al. Influence on cell proliferation of background radiation or exposure to very low, chronic γ radiation. Health Phys 1987; 52:571-578.
125. Satta L, Antonelli F, Belli M, et al. Influence of a low background radiation environment on biochemical and biological responses in V79 cells. Radiat Environ Biophys 2002; 41:217-224.
126. Caratero A, Courtade M, Bonnet L, Planel H, Caratero C. Effect of a continuous gamma irradiation at very low dose on the life span of mice. Gerontology 1998; 44:272-276.
127. Okajima S, Mine M, Nakamura T. Mortality of registered A-bomb survivors in Nagasaki, Japan. Radiat Res 1985; 103:419-431.
128. Shimizu Y, Pierce DA, Preston DL, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part II. Noncancer mortality: 1950-1990. Radiat Res 1999; 152:374-389.
129. Minois N. Longevity and aging: beneficial effects of exposure to mild stress. Biogerontology 2000; 1:15-29.
130. Boreham DR, Bahen ME, Laffrenier S, Mitchel REJ. Stress-induced radiation resistance in yeast. In: Sughara T, Sagan LA, Auyama T, eds. Low dose irradiation and biological defence mechanisms. Amsterdam: Elsevier Science; 1992:267-270.
131. Amundson SA, Do KT, Fornace AJ Jr. Induction of stress genes by low doses of gamma rays. Radiat Res 1999; 152:225-231.
132. Kusunoki Y, Yamaoka M, Kasagi F, et al. T cells of atomic bomb survivors respond poorly to stimulation by Staphylococcus aureus toxins in vitro: does this stem from their naive CD4 T-cell content? Radiat Res 2002; 158:715-724.
133. Liu SZ, Liu WH, Sun JB. Radiation hormesis: its expression in the immune system. Health Phys 1987; 52:579-583.
134. Chang WP, Hwang JS, Hung MC, Hu TH, Lee SD, Hwang BF. Chronic low-dose gamma-radiation exposure and the alteration of the distribution of lymphocyte subpopulations in residents of radioactive buildings. Int J Radiat Biol 1999; 75:1234-1239.
135. International Commission on Radiological Protection. Risk estimation for multifactorial diseases. ICRP Publication 83. Oxford: Pergamon, 1999.
136. Hei TK, Wu L-J, Liu S-X, Vannais D, Waldren CA, Randers-Pehrson G. Mutagenic effects of a single and exact number of α-particles in mammalian cells. Proc Natl Acad Sci USA 1997; 94:3765-3770.
137. Wu L-J, Randers-Pehrson G, Xu A, Waldren CA, Geard CR, Yu Z-L, Hei TK. Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc Natl Acad Sci U S A 1999; 96:4959-4964.
138. Goldberg Z, Lehnert BE. Radiation-induced effects in unirradiated cells: a review and implications in cancer. Int J Oncol 2002; 21:337-349.
139. Djordjevic B. Bystander effects: a concept in need of clarification. BioEssays 2000; 22:286-290.
140. Zhou H, Randers-Pehrson G, Waldren CA, Vannais D, Hall EJ, Hei TK. Induction of a bystander mutagenic effect of alpha particles in mammalian cells. Proc Natl Acad Sci USA 2000; 97:2099-2104.
141. Mothersill C, Seymour CB. Radiation-induced bystander effects: past history and future directions. Radiat Res 2001; 155:759-767.
142. Little JB, Azzam EI, de Toledo SM, Nagasawa H. Bystander effect: intercellular transmission of radiation damage signals. Radiat Prot Dosim 2002; 99:159-162.
143. Sawant SG, Randers-Pehrson G, Metting NF, Hall EJ. Adaptive response and the bystander effect induced by radiation in CH3 10T1/2 cells in culture. Radiat Res 2001; 156:177-180.
144. Zhou H, Suzuki M, Randers-Pehrson G, et al. Radiation risk to low fluences of α particles may be greater than we thought. Proc Natl Acad Sci USA 2001; 98:14410-14415.
145. Hall EJ. Radiation, the two-edged sword: cancer risks as high and low doses. Cancer J 2000; 6:343-350.
146. Iyer R, Lehnert BE. Alpha-particle-induced increases in the radioresistance of normal human bystander cells. Radiat Res 2002; 157:3-7.
147. Little MP, Wakeford R. The bystander effect in CH3 10T1/2 cells and radon-induced lung cancer. Radiat Res 2001; 156:695-699.
148. Seymour C, Mothersill C. Relative contribution of bystander and targeted cell killing to the low dose region of the radiation dose-repsonse curve. Radiat Res 2000; 153:508-511.
149. Brenner DJ, Sachs RK. Do low dose-rate bystander effects influence domestic radon risks? Int J Radiat Biol 2002; 78:593-604.
150. Harms-Ringdahl M. Some aspects on radiation induced transmissible genomic instability. Mutat Res 1998; 404:27-33.
151. Caron RM, Nagasawa H, Yu Y, Pfenning T, Vetrovs H, Little JB. Evidence for a role for genomic instability in radiation-induced mutagenesis. Radiat Oncol Invest 1997; 5:119-123.
152. Lorimore SA, Wright EG. Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to radiation-induced stress and injury? A review. Int J Radiat Biol 2003; 79:15-25.
153. Baverstock K. Radiation induced genomic instability: a paradigm-breaking phenomenon and its relevance to environmentally induced cancer. Mutat Res 2000; 454:89-109.
154. Mothersill C, Seymour C. Genomic instability, bystander effect and radiation risks: implications for development of protection strategies for man and the environment. Radiats Biol Radioecol 2000; 40:615-620.
155. Little JB. Radiation-induced genomic instability. Int J Radiat Biol 1998; 74:663-671.
156. Watson GE, Lorimore SA, MacDonald DA, Wright EG. Chromosomal instability in unirradiated cells induced in vivo by a bystander effect of ionizing radiation. Cancer Res 2000; 60:5608-5611.
157. Morgan WF, Hartmann A, Limili CL, Nagar S, Ponnaiya B. Bystander effects in radiation-induced genomic instability. Mutat Res 2002; 504:91-100.